BRWA
VRTX icon

B. Riley Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

B. Riley Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
2,403
+86
+4% +$38.1K 0.06% 271
2026
Q1 		$1.03M Sell
2,317
-1,138
-33% -$531K 0.07% 285
2025
Q4 		$1.57M Sell
3,455
-270
-7% -$116K 0.07% 252
2025
Q3 		$1.46M Sell
3,725
-416
-10% -$174K 0.07% 258
2025
Q2 		$1.84M Buy
+4,141
New +$1.91M 0.09% 226
2024
Q4 		$2.87M Sell
7,115
-1,881
-21% -$872K 0.09% 213
2024
Q3 		$4.14M Sell
8,996
-1,393
-13% -$669K 0.12% 183
2024
Q2 		$4.87M Buy
10,389
+946
+10% +$411K 0.12% 169
2024
Q1 		$3.28M Buy
9,443
+102
+1% +$43.1K 0.09% 220
2023
Q4 		$3.8M Sell
9,341
-102
-1% -$37.7K 0.1% 212
2023
Q3 		$3.28M Sell
9,443
-782
-8% -$273K 0.09% 220
2023
Q2 		$3.6M Sell
10,225
-2
-0% -$674 0.08% 239
2023
Q1 		$3.22M Sell
10,227
-5,638
-36% -$1.69M 0.09% 233
2022
Q4 		$4.58M Sell
15,865
-882
-5% -$269K 0.13% 177
2022
Q3 		$4.85M Buy
16,747
+1,057
+7% +$304K 0.15% 154
2022
Q2 		$4.42M Sell
15,690
-542
-3% -$145K 0.19% 120
2022
Q1 		$4.24M Buy
16,232
+4,418
+37% +$1.05M 0.14% 159
2021
Q4 		$2.6M Sell
11,814
-5,007
-30% -$974K 0.07% 284
2021
Q3 		$3.1M Buy
16,821
+1,104
+7% +$216K 0.1% 238
2021
Q2 		$3.2M Buy
15,717
+655
+4% +$137K 0.1% 229
2021
Q1 		$3.27M Buy
15,062
+2,912
+24% +$640K 0.12% 201
2020
Q4 		$2.87M Sell
12,150
-500
-4% -$115K 0.15% 152
2020
Q3 		$3.5M Buy
12,650
+3,181
+34% +$878K 0.19% 126
2020
Q2 		$2.75M Buy
9,469
+1,473
+18% +$399K 0.18% 134
2020
Q1 		$1.9M Buy
7,996
+2,551
+47% +$585K 0.16% 141
2019
Q4 		$1.19M Buy
5,445
+2,012
+59% +$407K 0.1% 219
2019
Q3 		$583K Buy
3,433
+824
+32% +$146K 0.06% 355
2019
Q2 		$480K Sell
2,609
-886
-25% -$155K 0.05% 393
2019
Q1 		$644K Buy
3,495
+186
+6% +$34.4K 0.08% 270
2018
Q4 		$549K Buy
3,309
+130
+4% +$22.5K 0.08% 273
2018
Q3 		$615K Sell
3,179
-79
-2% -$14.1K 0.07% 297
2018
Q2 		$555K Buy
3,258
+598
+22% +$92.7K 0.07% 297
2018
Q1 		$434K Buy
2,660
+594
+29% +$97K 0.06% 347
2017
Q4 		$310K Sell
2,066
-2,137
-51% -$316K 0.04% 432
2017
Q3 		$597K Buy
4,203
+2,344
+126% +$353K 0.1% 225
2017
Q2 		$240K Buy
+1,859
New +$224K 0.04% 431
2016
Q1 		– Sell
-2,271
Closed -$288K – 618
2015
Q4 		$288K Buy
+2,271
New +$274K 0.06% 376
2015
Q1 		– Sell
-484
Closed -$58 – 1958
2014
Q4 		$58 Buy
+484
New +$54.5K ﹤0.01% 2014
2014
Q3 		– Sell
-76
Closed -$7.19K – 1866
2014
Q2 		$7.19K Buy
+76
New +$5.33K ﹤0.01% 1920

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

B. Riley Wealth Advisors's VRTX Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 3.7% in Q2 2026, buying an estimated $38.1K and bringing the position to 2,403 shares worth $1.2M. The position accounts for 0.06% of the portfolio, ranked #271.

B. Riley Wealth Advisors first reported a position in VRTX in Q2 2014 and has held it in 39 quarters since. The position peaked at $4.87M in Q2 2024. 537 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • B. Riley Wealth Advisors held 2,403 shares of Vertex Pharmaceuticals worth $1.2M as of Q2 2026.
  • B. Riley Wealth Advisors bought 86 Vertex Pharmaceuticals shares in Q2 2026, an estimated $38.1K.
  • Vertex Pharmaceuticals made up 0.06% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #271 holding.
  • B. Riley Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2014 and has held it in 39 quarters since.
  • B. Riley Wealth Advisors's Vertex Pharmaceuticals position peaked at $4.87M in Q2 2024.
  • 537 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.